Acquisition of Antula completed

Acquisition of Antula completed

 

The competition authorities have approved Meda's acquisition of Antula
and the transaction has now been completed. The acquisition of Antula is
a consistent step in Meda's OTC strategy and offers Meda clear growth
opportunities.

For further inquiries, please contact:

Anders Larnholt, Vice President Corporate Development & IR ph: 46
709-458 878